Boston Advisors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,720
Closed -$202K 640
2017
Q4
$202K Sell
1,720
-400
-19% -$41.4K ﹤0.01% 622
2017
Q3
$209K Buy
+2,120
New +$189K ﹤0.01% 623
2017
Q1
Sell
-17,859
Closed -$1.54M 631
2016
Q4
$1.54M Buy
17,859
+515
+3% +$46K 0.04% 319
2016
Q3
$1.5M Sell
17,344
-3,249
-16% -$326K 0.04% 306
2016
Q2
$2.19M Buy
20,593
+248
+1% +$25.6K 0.05% 270
2016
Q1
$2.14M Buy
+20,345
New +$1.95M 0.05% 259
2015
Q4
Sell
-23,105
Closed -$2.09M 667
2015
Q3
$2.09M Sell
23,105
-70
-0.3% -$7.01K 0.08% 268
2015
Q2
$2.46M Buy
+23,175
New +$2.32M 0.1% 189

Other funds holding CRI

Boston Advisors's CRI Position: Q1 2018 in Review

Boston Advisors sold out of Carter's (CRI) in Q1 2018, closing a stake of 1,720 shares — an estimated $202K sold.

Boston Advisors first reported a position in CRI in Q2 2015 and held it in 8 quarters. The position peaked at $2.46M in Q2 2015. 384 funds tracked by Wall St. Rank hold CRI as of Q1 2018.

  • Boston Advisors reported no remaining Carter's position as of Q1 2018 after selling out during the quarter.
  • Boston Advisors sold 1,720 Carter's shares in Q1 2018, an estimated $202K.
  • Boston Advisors first reported a position in Carter's in Q2 2015 and held it in 8 quarters.
  • Boston Advisors's Carter's position peaked at $2.46M in Q2 2015.
  • 384 funds tracked by Wall St. Rank held Carter's as of Q1 2018.

Based on Boston Advisors's 13F filing for Q1 2018, filed 25 Apr 2018.